Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer in women globally. This subtype often has early and high recurrence rates resulting in poor survival, partially due to lack of targeted therapies. Therefore, there is an urgent need to identify TNBC-specific bi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Shin, V Y, Siu, J M, Cheuk, I, Ng, E K O, Kwong, A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647231/
https://ncbi.nlm.nih.gov/pubmed/25906045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados